Incidence of subclinical methemoglobinemia in infants with diarrhea

E S Pollack1, C V Pollack

  • 1Department of Emergency Medicine, Maricopa Medical Center, Phoenix, Arizona.

Insights

Infants with diarrhea, especially those small for their age, face a significant risk of developing methemoglobinemia. Early screening for this condition is recommended in ill infants presenting with diarrhea.

Area of Science:

  • Pediatrics
  • Clinical Chemistry

Background:

  • Diarrhea is a common pediatric illness.
  • Methemoglobinemia is a rare but serious condition.

Observation:

  • A prospective study of infants under 6 months with diarrhea revealed a high incidence of elevated methemoglobin.
  • Infants with weight at or below the tenth percentile for age showed a strong correlation with methemoglobinemia development.

Findings:

  • 64% of studied infants had elevated methemoglobin levels.
  • No correlation was found between methemoglobinemia and acidosis, hyperchloremia, or positive microbiologic studies.
  • Five patients required methylene blue treatment for methemoglobinemia, with full recovery.

Implications:

  • Consider screening for methemoglobinemia in infants with diarrhea, particularly those who are small for their age.
  • This finding highlights a greater-than-recognized risk in this vulnerable population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
196
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
154
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
713